Prevention
Tuberculosis prevention and control efforts rely primarily on the vaccination of infants and the detection and appropriate treatment of active cases. The World Health Organization has achieved some success with improved treatment regimens, and a small decrease in case numbers. The US Preventive Services Task Force (USPSTF) recommends screening people who are at high risk for latent tuberculosis with either tuberculin skin tests or interferon-gamma release assays.
TB education is also necessary for the general public. The public needs to know basic information about TB for a number of reasons including reducing the stigma still associated with TB.
TB prevention consists of two main parts. The first part of TB prevention is to stop the transmission of TB from one adult to another. This is done through firstly, identifying people with active TB, and then curing them through the provision of drug treatment. With proper TB treatment someone with TB will very quickly not be infectious and so can no longer spread the disease to others. The second main part of TB prevention is to prevent people with latent TB from developing active, and infectious, TB disease.
- TB treatment monitoring
- First line drugs for TB treatment
- Diagnosis & resistance Testing
- TB Prevention
Related Conference of Prevention
22nd International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
13th International Congress on Trauma, Critical Care and Emergency Medicine
Prevention Conference Speakers
Recommended Sessions
- : Causes of Tuberculosis
- Challenges in TB diagnostics
- Diagnosis
- Epidemiology of the disease
- Genome
- Intoduction to Tuberculosis
- Mycobacterium tuberculosis infection
- New research and development
- Pathogenesis
- Prevention
- Pulmonary disorders
- Resistance to TB drugs
- Surveillance and Tracking of Drug-Resistant TB
- Symptoms
- TB and HIV co-infection
- TB clinical trials
- Treatment (Vaccines & Immunization)
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Critical Care Medicine - TRAUMA 2027 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2027 (France)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2027 (France)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- Global Health and Trauma Care - TRAUMA 2027 (France)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric and Neonatal Emergency Care - TRAUMA 2027 (France)
- Resuscitation and Emergency Response - TRAUMA 2027 (France)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- Trauma and Emergency Medicine - TRAUMA 2027 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2027 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2027 (France)
